Skip to main content
Top
Published in: Cardiovascular Ultrasound 1/2015

Open Access 01-12-2015 | Research

The prognostic value of dobutamine stress echocardiography amongst British Indian Asian and Afro-Caribbean patients: a comparison with European white patients

Authors: Jamie M. O’Driscoll, Claire Rossato, Paula Gargallo-Fernandez, Marco Araco, Dimitrios Giannoglou, Sanjay Sharma, Rajan Sharma

Published in: Cardiovascular Ultrasound | Issue 1/2015

Login to get access

Abstract

Background

The incidence of cardiovascular disease is considerably disparate among different racial and ethnic populations. While dobutamine stress echocardiography (DSE) has been shown to be useful in Caucasian patients, its role among ethnic minority groups remains unclear. This study aimed to investigate the prognostic importance of DSE in three ethnic groups in the UK.

Methods

DSE was performed on 6231 consecutive patients. After exclusions, 5329 patients formed the study (2676 [50.2 %] Indian Asian, 2219 [41.6 %] European white and 434 [8.1 %] Afro-Caribbean). Study outcome measures were non-fatal cardiac events (NFCE) and all-cause mortality.

Results

There were 849 (15.9 %) NFCE and 1365 (25.6 %) deaths over a median follow-up period of 4.6 years. In total 1174 (22 %) patients had inducible myocardial ischaemia during DSE, 859 (16.1 %) had fixed wall motion abnormalities and 3645 (68.4 %) patients had a normal study. Ethnicity did not predict events. Among the three ethnic groups, ischaemia on DSE was associated with 2 to 2.5 times the risk of non-fatal cardiac events and 1.2 to 1.4 times the risk of all-cause mortality. Peak wall motion score index was the strongest independent predictor of non-fatal cardiac events and all-cause mortality in all groups. The C statistic for the prediction of NFCE and all-cause mortality were significantly higher when DSE parameters were added to the standard risk factors for all ethnic groups.

Conclusions

DSE is a strong predictor of NFCE and all-cause mortality and provides predictive information beyond that provided by standard risk factors in three major racial and ethnic groups. No major differences among racial and ethnic groups in the predictive value of DSE was detected.
Appendix
Available only for authorised users
Literature
1.
go back to reference Office of National Statistics. Ethnicity and National Identity in England and Wales 2011. Office of National Statistics. Ethnicity and National Identity in England and Wales 2011.
2.
go back to reference Feinstein M, Ning H, Kang J, Bertoni A, Carnethon M, Lloyd-Jones DM. Racial differences in risks for first cardiovascular events and noncardiovascular death: the Atherosclerosis Risk in Communities study, the Cardiovascular Health Study, and the Multi-Ethnic Study of Atherosclerosis. Circulation. 2012;126(1):50–9.CrossRefPubMedPubMedCentral Feinstein M, Ning H, Kang J, Bertoni A, Carnethon M, Lloyd-Jones DM. Racial differences in risks for first cardiovascular events and noncardiovascular death: the Atherosclerosis Risk in Communities study, the Cardiovascular Health Study, and the Multi-Ethnic Study of Atherosclerosis. Circulation. 2012;126(1):50–9.CrossRefPubMedPubMedCentral
3.
go back to reference Chambers JC, Eda S, Bassett P, Karim Y, Thompson SG, Gallimore JR, et al. C-reactive protein, insulin resistance, central obesity, and coronary heart disease risk in Indian Asians from the United Kingdom compared with European whites. Circulation. 2001;104(2):145–50.CrossRefPubMed Chambers JC, Eda S, Bassett P, Karim Y, Thompson SG, Gallimore JR, et al. C-reactive protein, insulin resistance, central obesity, and coronary heart disease risk in Indian Asians from the United Kingdom compared with European whites. Circulation. 2001;104(2):145–50.CrossRefPubMed
4.
go back to reference Hozawa A, Folsom AR, Sharrett AR, Chambless LE. Absolute and attributable risks of cardiovascular disease incidence in relation to optimal and borderline risk factors: comparison of African American with white subjects--Atherosclerosis Risk in Communities Study. Arch Intern Med. 2007;167(6):573–9.CrossRefPubMed Hozawa A, Folsom AR, Sharrett AR, Chambless LE. Absolute and attributable risks of cardiovascular disease incidence in relation to optimal and borderline risk factors: comparison of African American with white subjects--Atherosclerosis Risk in Communities Study. Arch Intern Med. 2007;167(6):573–9.CrossRefPubMed
5.
go back to reference Scarborough P, Bhatnagar P, Kaur A. Smolina K. Wickramasinghe: Rayner M. Ethnic Differences in Cardiovascular Disease. Department of Health. University of Oxford; 2010. Scarborough P, Bhatnagar P, Kaur A. Smolina K. Wickramasinghe: Rayner M. Ethnic Differences in Cardiovascular Disease. Department of Health. University of Oxford; 2010.
6.
go back to reference Kim CX, Bailey KR, Klee GG, Ellington AA, Liu G, Mosley Jr TH, et al. Sex and ethnic differences in 47 candidate proteomic markers of cardiovascular disease: the Mayo Clinic proteomic markers of arteriosclerosis study. PLoS One. 2010;5(2):e9065.CrossRefPubMedPubMedCentral Kim CX, Bailey KR, Klee GG, Ellington AA, Liu G, Mosley Jr TH, et al. Sex and ethnic differences in 47 candidate proteomic markers of cardiovascular disease: the Mayo Clinic proteomic markers of arteriosclerosis study. PLoS One. 2010;5(2):e9065.CrossRefPubMedPubMedCentral
7.
go back to reference Zhang T, Tsang W, Wijeysundera HC, Ko DT. Reporting and representation of ethnic minorities in cardiovascular trials: a systematic review. Am Heart J. 2013;166(1):52–7.CrossRefPubMed Zhang T, Tsang W, Wijeysundera HC, Ko DT. Reporting and representation of ethnic minorities in cardiovascular trials: a systematic review. Am Heart J. 2013;166(1):52–7.CrossRefPubMed
8.
go back to reference Prakash M, Partington S, Froelicher VF, Heidenreich PA, Myers J. The effect of ethnicity on survival in male veterans referred for electrocardiography and treadmill testing. Arch Intern Med. 2003;163(18):2204–10.CrossRefPubMed Prakash M, Partington S, Froelicher VF, Heidenreich PA, Myers J. The effect of ethnicity on survival in male veterans referred for electrocardiography and treadmill testing. Arch Intern Med. 2003;163(18):2204–10.CrossRefPubMed
9.
go back to reference Chuah SC, Pellikka PA, Roger VL, McCully RB, Seward JB. Role of dobutamine stress echocardiography in predicting outcome in 860 patients with known or suspected coronary artery disease. Circulation. 1998;97(15):1474–80.CrossRefPubMed Chuah SC, Pellikka PA, Roger VL, McCully RB, Seward JB. Role of dobutamine stress echocardiography in predicting outcome in 860 patients with known or suspected coronary artery disease. Circulation. 1998;97(15):1474–80.CrossRefPubMed
10.
go back to reference Krivokapich J, Child JS, Walter DO, Garfinkel A. Prognostic value of dobutamine stress echocardiography in predicting cardiac events in patients with known or suspected coronary artery disease. J Am Coll Cardiol. 1999;33(3):708–16.CrossRefPubMed Krivokapich J, Child JS, Walter DO, Garfinkel A. Prognostic value of dobutamine stress echocardiography in predicting cardiac events in patients with known or suspected coronary artery disease. J Am Coll Cardiol. 1999;33(3):708–16.CrossRefPubMed
11.
go back to reference Poldermans D, Fioretti PM, Boersma E, Cornel JH, Borst F, Vermeulen EG, et al. Dobutamine-atropine stress echocardiography and clinical data for predicting late cardiac events in patients with suspected coronary artery disease. Am J Med. 1994;97(2):119–25.CrossRefPubMed Poldermans D, Fioretti PM, Boersma E, Cornel JH, Borst F, Vermeulen EG, et al. Dobutamine-atropine stress echocardiography and clinical data for predicting late cardiac events in patients with suspected coronary artery disease. Am J Med. 1994;97(2):119–25.CrossRefPubMed
12.
go back to reference Steinberg EH, Madmon L, Patel CP, Sedlis SP, Kronzon I, Cohen JL. Long-term prognostic significance of dobutamine echocardiography in patients with suspected coronary artery disease: results of a 5-year follow-up study. J Am Coll Cardiol. 1997;29(5):969–73.CrossRefPubMed Steinberg EH, Madmon L, Patel CP, Sedlis SP, Kronzon I, Cohen JL. Long-term prognostic significance of dobutamine echocardiography in patients with suspected coronary artery disease: results of a 5-year follow-up study. J Am Coll Cardiol. 1997;29(5):969–73.CrossRefPubMed
13.
go back to reference Bernheim AM, Kittipovanonth M, Takahashi PY, Gharacholou SM, Scott CG, Pellikka PA. Does the prognostic value of dobutamine stress echocardiography differ among different age groups? Am Heart J. 2011;161(4):740–5.CrossRefPubMed Bernheim AM, Kittipovanonth M, Takahashi PY, Gharacholou SM, Scott CG, Pellikka PA. Does the prognostic value of dobutamine stress echocardiography differ among different age groups? Am Heart J. 2011;161(4):740–5.CrossRefPubMed
14.
go back to reference Shaw LJ, Vasey C, Sawada S, Rimmerman C, Marwick TH. Impact of gender on risk stratification by exercise and dobutamine stress echocardiography: long-term mortality in 4234 women and 6898 men. Eur Heart J. 2005;26(5):447–56.CrossRefPubMed Shaw LJ, Vasey C, Sawada S, Rimmerman C, Marwick TH. Impact of gender on risk stratification by exercise and dobutamine stress echocardiography: long-term mortality in 4234 women and 6898 men. Eur Heart J. 2005;26(5):447–56.CrossRefPubMed
15.
go back to reference Cortigiani L, Bigi R, Sicari R, Landi P, Bovenzi F, Picano E. Prognostic value of pharmacological stress echocardiography in diabetic and nondiabetic patients with known or suspected coronary artery disease. J Am Coll Cardiol. 2006;47(3):605–10.CrossRefPubMed Cortigiani L, Bigi R, Sicari R, Landi P, Bovenzi F, Picano E. Prognostic value of pharmacological stress echocardiography in diabetic and nondiabetic patients with known or suspected coronary artery disease. J Am Coll Cardiol. 2006;47(3):605–10.CrossRefPubMed
16.
go back to reference Sharma R, Pellerin D, Gaze DC, Gregson H, Streather CP, Collinson PO, et al. Dobutamine stress echocardiography and the resting but not exercise electrocardiograph predict severe coronary artery disease in renal transplant candidates. Nephrol Dial Transplant. 2005;20(10):2207–14.CrossRefPubMed Sharma R, Pellerin D, Gaze DC, Gregson H, Streather CP, Collinson PO, et al. Dobutamine stress echocardiography and the resting but not exercise electrocardiograph predict severe coronary artery disease in renal transplant candidates. Nephrol Dial Transplant. 2005;20(10):2207–14.CrossRefPubMed
17.
go back to reference McCully RB, Roger VL, Mahoney DW, Karon BL, Oh JK, Miller Jr FA, et al. Outcome after normal exercise echocardiography and predictors of subsequent cardiac events: follow-up of 1,325 patients. J Am Coll Cardiol. 1998;31(1):144–9.CrossRefPubMed McCully RB, Roger VL, Mahoney DW, Karon BL, Oh JK, Miller Jr FA, et al. Outcome after normal exercise echocardiography and predictors of subsequent cardiac events: follow-up of 1,325 patients. J Am Coll Cardiol. 1998;31(1):144–9.CrossRefPubMed
18.
go back to reference McNeill AJ, Fioretti PM. el-Said SM, Salustri A, Forster T, Roelandt JR. Enhanced sensitivity for detection of coronary artery disease by addition of atropine to dobutamine stress echocardiography. Am J Cardiol. 1992;70(1):41–6.CrossRefPubMed McNeill AJ, Fioretti PM. el-Said SM, Salustri A, Forster T, Roelandt JR. Enhanced sensitivity for detection of coronary artery disease by addition of atropine to dobutamine stress echocardiography. Am J Cardiol. 1992;70(1):41–6.CrossRefPubMed
19.
go back to reference Cerqueira MD, Weissman NJ, Dilsizian V, Jacobs AK, Kaul S, Laskey WK, et al. Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart: a statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association. Circulation. 2002;105(4):539–42.CrossRefPubMed Cerqueira MD, Weissman NJ, Dilsizian V, Jacobs AK, Kaul S, Laskey WK, et al. Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart: a statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association. Circulation. 2002;105(4):539–42.CrossRefPubMed
20.
go back to reference Devereux RB, Alonso DR, Lutas EM, Gottlieb GJ, Campo E, Sachs I, et al. Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings. Am J Cardiol. 1986;57(6):450–8.CrossRefPubMed Devereux RB, Alonso DR, Lutas EM, Gottlieb GJ, Campo E, Sachs I, et al. Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings. Am J Cardiol. 1986;57(6):450–8.CrossRefPubMed
21.
go back to reference Armstrong WF. Stress echocardiography for detection of coronary artery disease. Circulation. 1991;84(3 Suppl):I43–9.PubMed Armstrong WF. Stress echocardiography for detection of coronary artery disease. Circulation. 1991;84(3 Suppl):I43–9.PubMed
22.
go back to reference Rizzello V, Poldermans D, Schinkel AF, Biagini E, Boersma E, Elhendy A, et al. Long term prognostic value of myocardial viability and ischaemia during dobutamine stress echocardiography in patients with ischaemic cardiomyopathy undergoing coronary revascularisation. Heart. 2006;92(2):239–44.CrossRefPubMed Rizzello V, Poldermans D, Schinkel AF, Biagini E, Boersma E, Elhendy A, et al. Long term prognostic value of myocardial viability and ischaemia during dobutamine stress echocardiography in patients with ischaemic cardiomyopathy undergoing coronary revascularisation. Heart. 2006;92(2):239–44.CrossRefPubMed
23.
go back to reference Sharma R, Mehta RL, Brecker SJ, Gaze DC, Gregson H, Streather CP, et al. The diagnostic and prognostic value of tissue Doppler imaging during dobutamine stress echocardiography in end-stage renal disease. Coron Artery Dis. 2009;20(3):230–7.CrossRefPubMed Sharma R, Mehta RL, Brecker SJ, Gaze DC, Gregson H, Streather CP, et al. The diagnostic and prognostic value of tissue Doppler imaging during dobutamine stress echocardiography in end-stage renal disease. Coron Artery Dis. 2009;20(3):230–7.CrossRefPubMed
24.
go back to reference Detrano R, Guerci AD, Carr JJ, Bild DE, Burke G, Folsom AR, et al. Coronary calcium as a predictor of coronary events in four racial or ethnic groups. N Engl J Med. 2008;358(13):1336–45.CrossRefPubMed Detrano R, Guerci AD, Carr JJ, Bild DE, Burke G, Folsom AR, et al. Coronary calcium as a predictor of coronary events in four racial or ethnic groups. N Engl J Med. 2008;358(13):1336–45.CrossRefPubMed
25.
go back to reference Folsom AR, Kronmal RA, Detrano RC, O'Leary DH, Bild DE, Bluemke DA, et al. Coronary artery calcification compared with carotid intima-media thickness in the prediction of cardiovascular disease incidence: the Multi-Ethnic Study of Atherosclerosis (MESA). Arch Intern Med. 2008;168(12):1333–9.CrossRefPubMedPubMedCentral Folsom AR, Kronmal RA, Detrano RC, O'Leary DH, Bild DE, Bluemke DA, et al. Coronary artery calcification compared with carotid intima-media thickness in the prediction of cardiovascular disease incidence: the Multi-Ethnic Study of Atherosclerosis (MESA). Arch Intern Med. 2008;168(12):1333–9.CrossRefPubMedPubMedCentral
26.
go back to reference Biagini E, Elhendy A, Bax JJ, Rizzello V, Schinkel AF, van Domburg RT, et al. Seven-year follow-up after dobutamine stress echocardiography: impact of gender on prognosis. J Am Coll Cardiol. 2005;45(1):93–7.CrossRefPubMed Biagini E, Elhendy A, Bax JJ, Rizzello V, Schinkel AF, van Domburg RT, et al. Seven-year follow-up after dobutamine stress echocardiography: impact of gender on prognosis. J Am Coll Cardiol. 2005;45(1):93–7.CrossRefPubMed
27.
go back to reference Biagini E, Elhendy A, Schinkel AF, Rizzello V, Bax JJ, Sozzi FB, et al. Long-term prediction of mortality in elderly persons by dobutamine stress echocardiography. J Gerontol A Biol Sci Med Sci. 2005;60(10):1333–8.CrossRefPubMed Biagini E, Elhendy A, Schinkel AF, Rizzello V, Bax JJ, Sozzi FB, et al. Long-term prediction of mortality in elderly persons by dobutamine stress echocardiography. J Gerontol A Biol Sci Med Sci. 2005;60(10):1333–8.CrossRefPubMed
28.
go back to reference Chaowalit N, Arruda AL, McCully RB, Bailey KR, Pellikka PA. Dobutamine stress echocardiography in patients with diabetes mellitus: enhanced prognostic prediction using a simple risk score. J Am Coll Cardiol. 2006;47(5):1029–36.CrossRefPubMed Chaowalit N, Arruda AL, McCully RB, Bailey KR, Pellikka PA. Dobutamine stress echocardiography in patients with diabetes mellitus: enhanced prognostic prediction using a simple risk score. J Am Coll Cardiol. 2006;47(5):1029–36.CrossRefPubMed
29.
go back to reference Elhendy A, Sozzi F, van Domburg RT, Bax JJ, Schinkel AF, Roelandt JR, et al. Effect of myocardial ischemia during dobutamine stress echocardiography on cardiac mortality in patients with heart failure secondary to ischemic cardiomyopathy. Am J Cardiol. 2005;96(4):469–73.CrossRefPubMed Elhendy A, Sozzi F, van Domburg RT, Bax JJ, Schinkel AF, Roelandt JR, et al. Effect of myocardial ischemia during dobutamine stress echocardiography on cardiac mortality in patients with heart failure secondary to ischemic cardiomyopathy. Am J Cardiol. 2005;96(4):469–73.CrossRefPubMed
30.
go back to reference Marwick TH, Case C, Sawada S, Rimmerman C, Brenneman P, Kovacs R, et al. Prediction of mortality using dobutamine echocardiography. J Am Coll Cardiol. 2001;37(3):754–60.CrossRefPubMed Marwick TH, Case C, Sawada S, Rimmerman C, Brenneman P, Kovacs R, et al. Prediction of mortality using dobutamine echocardiography. J Am Coll Cardiol. 2001;37(3):754–60.CrossRefPubMed
31.
go back to reference Sozzi FB, Elhendy A, Roelandt JR, van Domburg RT, Schinkel AF, Vourvouri EC, et al. Prognostic value of dobutamine stress echocardiography in patients with diabetes. Diabetes Care. 2003;26(4):1074–8.CrossRefPubMed Sozzi FB, Elhendy A, Roelandt JR, van Domburg RT, Schinkel AF, Vourvouri EC, et al. Prognostic value of dobutamine stress echocardiography in patients with diabetes. Diabetes Care. 2003;26(4):1074–8.CrossRefPubMed
32.
go back to reference Chaturvedi N, Athanassopoulos G, McKeigue PM, Marmot MG, Nihoyannopoulos P. Echocardiographic measures of left ventricular structure and their relation with rest and ambulatory blood pressure in blacks and whites in the United Kingdom. J Am Coll Cardiol. 1994;24(6):1499–505.CrossRefPubMed Chaturvedi N, Athanassopoulos G, McKeigue PM, Marmot MG, Nihoyannopoulos P. Echocardiographic measures of left ventricular structure and their relation with rest and ambulatory blood pressure in blacks and whites in the United Kingdom. J Am Coll Cardiol. 1994;24(6):1499–505.CrossRefPubMed
33.
go back to reference Levy D, Garrison RJ, Savage DD, Kannel WB, Castelli WP. Left ventricular mass and incidence of coronary heart disease in an elderly cohort. The Framingham Heart Study. Ann Intern Med. 1989;110(2):101–7.CrossRefPubMed Levy D, Garrison RJ, Savage DD, Kannel WB, Castelli WP. Left ventricular mass and incidence of coronary heart disease in an elderly cohort. The Framingham Heart Study. Ann Intern Med. 1989;110(2):101–7.CrossRefPubMed
34.
go back to reference Park CM, March K, Ghosh AK, Jones S, Coady E, Tuson C, et al. Left-ventricular structure in the Southall And Brent REvisited (SABRE) study: explaining ethnic differences. Hypertension. 2013;61(5):1014–20.CrossRefPubMedPubMedCentral Park CM, March K, Ghosh AK, Jones S, Coady E, Tuson C, et al. Left-ventricular structure in the Southall And Brent REvisited (SABRE) study: explaining ethnic differences. Hypertension. 2013;61(5):1014–20.CrossRefPubMedPubMedCentral
35.
go back to reference Chahal NS, Lim TK, Jain P, Chambers JC, Kooner JS, Senior R. Ethnicity-related differences in left ventricular function, structure and geometry: a population study of UK Indian Asian and European white subjects. Heart. 2010;96(6):466–71.CrossRefPubMed Chahal NS, Lim TK, Jain P, Chambers JC, Kooner JS, Senior R. Ethnicity-related differences in left ventricular function, structure and geometry: a population study of UK Indian Asian and European white subjects. Heart. 2010;96(6):466–71.CrossRefPubMed
36.
go back to reference Gardin JM, Wagenknecht LE, Anton-Culver H, Flack J, Gidding S, Kurosaki T, et al. Relationship of cardiovascular risk factors to echocardiographic left ventricular mass in healthy young black and white adult men and women. The CARDIA study. Coronary Artery Risk Development in Young Adults. Circulation. 1995;92(3):380–7.CrossRefPubMed Gardin JM, Wagenknecht LE, Anton-Culver H, Flack J, Gidding S, Kurosaki T, et al. Relationship of cardiovascular risk factors to echocardiographic left ventricular mass in healthy young black and white adult men and women. The CARDIA study. Coronary Artery Risk Development in Young Adults. Circulation. 1995;92(3):380–7.CrossRefPubMed
37.
38.
go back to reference Jones DA, Gallagher S, Rathod KS, Redwood S, de Belder MA, Mathur A, et al. Mortality in South Asians and Caucasians after percutaneous coronary intervention in the United Kingdom: an observational cohort study of 279,256 patients from the BCIS (British Cardiovascular Intervention Society) National Database. JACC Cardiovasc Interv. 2014;7(4):362–71.CrossRefPubMed Jones DA, Gallagher S, Rathod KS, Redwood S, de Belder MA, Mathur A, et al. Mortality in South Asians and Caucasians after percutaneous coronary intervention in the United Kingdom: an observational cohort study of 279,256 patients from the BCIS (British Cardiovascular Intervention Society) National Database. JACC Cardiovasc Interv. 2014;7(4):362–71.CrossRefPubMed
39.
go back to reference Liao Y, Ghali JK, Berzins L, Cooper RS. Coronary angiographic findings in African-American and white patients from a single institution. J Natl Med Assoc. 2001;93(12):465–74.PubMedPubMedCentral Liao Y, Ghali JK, Berzins L, Cooper RS. Coronary angiographic findings in African-American and white patients from a single institution. J Natl Med Assoc. 2001;93(12):465–74.PubMedPubMedCentral
40.
go back to reference Baker J, Mitchell R, Lawson K, Pell J. Ethnic differences in the cost-effectiveness of targeted and mass screening for high cardiovascular risk in the UK: cross-sectional study. Heart. 2013;99(23):1766–71.CrossRefPubMed Baker J, Mitchell R, Lawson K, Pell J. Ethnic differences in the cost-effectiveness of targeted and mass screening for high cardiovascular risk in the UK: cross-sectional study. Heart. 2013;99(23):1766–71.CrossRefPubMed
41.
go back to reference Lauer MS, Blackstone EH, Young JB, Topol EJ. Cause of death in clinical research: time for a reassessment? J Am Coll Cardiol. 1999;34(3):618–20.CrossRefPubMed Lauer MS, Blackstone EH, Young JB, Topol EJ. Cause of death in clinical research: time for a reassessment? J Am Coll Cardiol. 1999;34(3):618–20.CrossRefPubMed
Metadata
Title
The prognostic value of dobutamine stress echocardiography amongst British Indian Asian and Afro-Caribbean patients: a comparison with European white patients
Authors
Jamie M. O’Driscoll
Claire Rossato
Paula Gargallo-Fernandez
Marco Araco
Dimitrios Giannoglou
Sanjay Sharma
Rajan Sharma
Publication date
01-12-2015
Publisher
BioMed Central
Published in
Cardiovascular Ultrasound / Issue 1/2015
Electronic ISSN: 1476-7120
DOI
https://doi.org/10.1186/s12947-015-0028-1

Other articles of this Issue 1/2015

Cardiovascular Ultrasound 1/2015 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.